TrialArthritis care & research2020

Efficacy and Safety of Intravenous Golimumab Through One Year in Patients With Active Psoriatic Arthritis.

M Elaine Husni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.